Searchable abstracts of presentations at key conferences in endocrinology

ea0025oc5.1 | Reproduction and fetal programming | SFEBES2011

The effect of a maternal low protein diet on renal development and function in the offspring

Lloyd Louise , Rhodes Philip , Rhind Stuart , Gardner David

Background: Previous studies have linked a low protein maternal diet with hypertension in adult offspring, and have suggested that impaired kidney development may be an important predisposing factor. This study aims to identify the molecular and structural changes that explain the decline in function.Methods: Pregnant ewes were fed either a control diet providing adequate dietary protein (control protein (CP); n=15), or a low protein diet during e...

ea0025p285 | Steroids | SFEBES2011

Measurement of salivary testosterone in female samples using a highly sensitive LC–MS/MS assay

Keevil Brian , McDonald Philip , McDowell Wendy , Wallace Alan , Wu Fred

Introduction: We have developed a highly sensitive LC–MS assay in an attempt to improve the measurement of salivary testosterone in female samples.Methods: A 200 μl saliva sample, calibrators or QC were mixed with 10 μl working internal standard (0.1 μg/l) and 1 ml of methyl tert-butyl ether (MTBE). Vortex mixed for 4 min and frozen at −80 °C (1 h). Unfrozen organic layer was transferred to a glass tube and evaporated. The ...

ea0023oc1.2 | Oral Communications 1 | BSPED2009

Altered GH/IGF1 signalling in children born small for gestational age without catch up growth

Butcher Imogen , Whatmore Andrew , Murray Philip , Westwood Melissa , Clayton Peter

Background: Infants born small for gestational age (SGA) usually show catch-up growth during the first few years of post-natal life. However, some infants remain small and little is known about the factors governing their growth failure. GH and IGF1 receptor mutations only account for a minority of cases. We have now initiated an in vitro assessment of signalling molecules downstream of these receptors and evaluation of cell growth characteristics.<p class="abstext"...

ea0023p30 | (1) | BSPED2009

Congenital hypothyroidism – A thirty year audit of the National Newborn Screening Programme in the Republic of Ireland

McDonnell Ciara , Carroll Aoife , Dockeray Sylvia , Mayne Philip , Murphy Nuala

Introduction: Congenital hypothyroidism (CHT) has a reported incidence of 1:3500 in Caucasian populations. Early detection by newborn screening and appropriate L-thyroxine treatment leads to normal or near-normal neurocognitive outcome.The National Newborn screening programme (NNP) was established in Children’s University Hospital, Temple St. in 1979. This study aimed to ascertain the incidence of congenital hypothyroidism in the Republic of Ireland...

ea0021p74 | Clinical practice/governance and case reports | SFEBES2009

A case of connective tissue disease complicated by multiple metabolic disorders

Piya Milan , Tahrani Abd , Dyer Philip , Shakher Jayadave , Jones Alan

A 24-year-old Pakistani woman presented one day after returning from a 6-week holiday in Pakistan with a 3-day history of generalised weakness, difficulty in walking and left flank pain. She was known to have mixed connective tissue disease (MCTD). Clinically she was pyrexial and had generalised muscular weakness (power 3/5), and hypotonia. Biochemically, she was found to have hypokalaemia (1.8 mmol/l), raised serum urea (8.1 mmol/l), and creatinine (160 μmol/l), high ESR...

ea0021p227 | Growth and development | SFEBES2009

Altered responses to GH and IGF1 in children born small for gestational age without post-natal catch up growth

Butcher Imogen , Whatmore Andrew , Murray Philip , Westwood Melissa , Clayton Peter

Background: Infants born small for gestational age (SGA) usually show catch up growth within the first few years of life. However in the UK ~1500 SGA children each year remain small, with no clear endocrine cause with rare genetic syndromes accounting for only a minority of cases. In order to define growth factor activation in these children we have initiated an assessment of cell growth and signalling in response to GH and IGF1 in fibroblast cell lines....

ea0021p337 | Steroids | SFEBES2009

Determination of tandem mass spectrometry specific reference ranges for testosterone, androstenedione and DHEAS

Macdonald Philip , Wu Frederick , Owen Laura , Keevil Brian

Testosterone, androstenedione and DHEAS are commonly measured by immunoassays. Variations in antibody specificity and calibration of assays results in non-commutability of measurements. Even more specific mass spectrometry (LC–MS/MS) assays still exhibit differences in calibration. As the use of mass spectrometry for measuring steroids is becoming more common in the clinical laboratory, the development of LC–MS/MS reference ranges for these analytes is essential to h...

ea0016p520 | Obesity | ECE2008

Changes of the testosterone levels in young males with obesity and metabolic syndrome

Robeva Ralitza , Kirilov Georgi , Tomova Analia , Kumanov Philip

Aim: The present study aimed to compare the androgen levels in men with obesity, metabolic syndrome /MS/ and healthy normal – weight controls.Materials and methods: Eighty-six males (mean age 29.65±8.57 /18–50/) were investigated. 31 of them were healthy (mean BMI – 23.66±1.97); 22 were with simple obesity (mean BMI – 32.79±7.16) and 33 (mean BMI – 35.78±8.71) were with overt metabolic syndrome /MS/ according ...

ea0016p617 | Reproduction | ECE2008

Anti-Mullerian hormone levels in women with polycystic ovary syndrome before and after metformin therapy

Tomova Analia , Robeva Ralitza , Kumanov Philip , Kirilov Georgi , Mechandjiev Zvetozar

Recently was established, that in the ovary Anti-Müllerian hormone (AMH) is produced by the granulose cells and correlated with the count of small antral follicles. As AMH is largely expressed throughout folliculogenesis, it is considered that the serum levels of AMH may represent both the quantity and quality of the ovarian follicle pool. To determine the changes of AMH in women with polycystic ovary syndrome (PCOS) we have studied 22 patients with this disorder and comp...

ea0015p81 | Clinical practice/governance and case reports | SFEBES2008

Nasal polyps: an unusual presentation of macroprolactinomas

Johnston Philip , Courtney Hamish , Hunter Steven , Mc Cance David

Intranasal presentations of pituitary tumours are rare. Management can be difficult and delayed due to their location and extension. Macroprolactinomas are uncommon and can often pursue an aggressive clinical course, including invasion into the nasopharynx.We describe three cases of prolactinomas that initially presented to the ENT Department as nasal polyps. Table 1 highlights their clinical features and response to treatment. Recurrence of nasal polyps...